October 2010

 

In this Issue

The Retina Pipeline

  • Issue

  • Insert

  • Supplement

  • Supplement

 

NEWS

Radiation Therapy for Age-Related Macular Degeneration

Two investigational devices are designed to provide targeted delivery of radiation to reduce damage to the optic nerve and surrounding tissues.

By Compiled BY Jennifer Kreatsoulas, PHD, Senior Associate Editor

Intensive Training Program Offers European Surgeons Unique Learning Opportunity

The European VitreoRetinal Training School (EVRTS) brings newer surgeons together with the experts in retina.

By Rachel M. Renshaw, Editor-In-Chief

BUSINESS OF RETINA

The Retina Specialist’s Field Guide to Site Selection

By Avner Ingerman, MD, MSC; Ashley Lafond; and David Waters-Honcu

FELLOWS’ FOCUS: Finding Professional and Personal Balance as a Fellow: Part 2

By Eugene A. Milder, MD; Paul S. Baker, MD; and Allen Chiang, MD; with Jason HSU, MD; and Carl Park, MD

RETINA IN THE ASC: Challenges of Being a Well-rounded Retina Specialist

With the right strategy, one can happily manage multiple commitments.

By J. Fernando Arevalo, MD, FACS

RETINA SURGERY

GLOBAL PERSPECTIVES: Advanced Training in Retinal Diseases

The European School for Advanced Studies in Ophthalmology offers young physicians an interdisciplinary and international postgraduate training experience.

By Stanislao Rizzo, MD; and Giuseppe Guarnaccia, MD

RETINA PEARLS: Fundus Visualization With Wide-angle Viewing Systems

These devices allow surgeons to recognize fundus pathology and treat lesions safely and effectively.

By Masahito Ohji, MD

RETINAL ONCOLOGY

CASE REPORTS IN OCULAR ONCOLOGY: Small Choroidal Melanoma With All Eight Risk Factors for Growth

By Felina V. Zolotarev, BA; Kiran Turka, MD; and Carol L. Shields, MD

COVER STORIES

Complement Factor 5 Inhibition in Age-related Macular Degeneration

ARC1905 shows promise for enhanced efficacy in eyes with wet AMD.

By Jordi Monés, MD

Preliminary Results With Noninvasive Radiation Therapy for Wet AMD

By Peter K. Kaiser, MD; and Viriglio Morales-Canton, MD

Dexamethasone Implant for Treatment of DME in Vitrectomized Patients

A prospective, 6-month, open-label study shows promising results.

By Leonard Feiner, MD

CNTF-secreting Implant for Geographic Atrophy

Eighteen-month results show device to be well-tolerated with no serious adverse events.

By Glenn J. Jaffe, MD

Reducing the Treatment Burden for AMD

Combination therapy with anti-VEGF plus epimacular brachytherapy holds promise.

By Pravin U. Dugel, MD

Fluocinolone Insert’s Impact on Overall Risk of Procedures

In an analysis of FAME study data, risk of subsequent procedures was reduced in treated patients.

By P. Andrew Pearson, MD

Human Visual Cycle Modulation for Dry AMD

Novel oral nonretinoid treatment targets visual cycle process that creates toxic byproducts implicated in retinal diseases.

By Nancy Boman, MD, PHD

RETINA SURGERY

Panretinal Photocoagulation in Patients with DME

Laser remains the mainstay of treatment in DME.

By Pascale Massin, MD

DEPARTMENTS

INNOVATIONS

A preview of today’s new products

5 Questions with Susanne Binder, MD

Dr. Binder is Professor and Chairman of the Department of Ophthalmology of the Ludwig Boltzmann Institute for Retinology and Biomicroscopic Laser Surgery, Rudolf Foundation Clinic, in Vienna, Austria.

 

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Scott Krzywonos
Editor-in-Chief
484-581-1880
skrzywonos@bmctoday.com

Janet Burk
Publisher
214-394-3551
jburk@bmctoday.com

About Retina Today

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.